Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Bank On It

IPT speaks to Kirstin Goldring of AstraZeneca to learn more about biobanking standards, legislative demands, and expected advances within the sector in the decade ahead.

Dr Kirstin Goldring, AstraZeneca (March 2015)

Keywords: Human biological samples, Governance structures, Consent forms, Sample pre-analytical codes

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |